Pediatric Hematology and Oncology

Papers
(The TQCC of Pediatric Hematology and Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
The time to diagnosis and survival in children with solid tumors and lymphoma: results from a single center in Turkey18
Aceruloplasminemia presenting with microcytic anemia in a Turkish boy due to a novel pathogenic variant10
The role of pediatric oncologist in prenatal diagnosis: A 10-year retrospective study at Assistance Publique Hôpitaux de Marseille (AP-HM)10
The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting10
Environmental health disparities in pediatric cancer: a report from the Fourth Symposium on Childhood Cancer Health Disparities8
A brief review of the current knowledge on environmental toxicants and risk of pediatric cancers8
MicroRNA-199a deficiency relates to higher bone marrow blasts, poor risk stratification and worse prognostication in pediatric acute myeloid leukemia patients8
Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis7
The expression of PHOX2B in bone marrow and peripheral blood predicts adverse clinical outcome in non-high-risk neuroblastoma7
Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii7
Prognostic significance of survivin expression in pediatric ewing sarcoma7
Rivaroxaban for Management of Venous Thromboembolism in Pediatric Nephrotic Syndrome; a Case Report and Review of Literature7
Development and pilot implementation of an activity-based emotional support intervention for caregivers of children with cancer7
Myelofibrosis associated with immune cytopenia in an infant: a diagnostic and therapeutic challenge6
Outcome of pediatric germ cell tumor with comparison of carboplatin and cisplatin based regimens: A 10-year analysis6
Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature6
GATA2-related myeloid neoplasms in pediatrics: where do we stand?6
Response to neoadjuvant selpercatinib in a pediatric patient with advanced papillary thyroid carcinoma: a case report6
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report5
Comparative analysis of a novel next-generation sequencing-based IGH clonality assay for measurable residual disease detection in pediatric B-cell acute lymphoblastic leukemia patients5
Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument5
Temporal trends and unbalanced distribution, in pediatric cutaneous melanoma in 204 countries and territories, 1990-20195
Treatment outcomes in patients with Ewing sarcoma of the spine in a resource-challenged setting: 17-year experience from a single center in India5
Factors Related to the Quality of Life in Children with Transfusion-Dependent Thalassemia5
MiR-143-3p Inhibits Cell Proliferation in Pedatric Acute Myeloid Leukemia via Inhibition of KAT6A5
Effect of platelet count and platelet transfusion on fever duration in patients with febrile neutropenia5
Gross motor disorders in pediatric patients with acute lymphoblastic leukemia and survivors: A systematic review4
Acute myeloid leukemia in a child with familial platelet disorder and a cryptic runx1 intragenic deletion4
Assessment of plasminogen activator inhibitor-1(PAI1) and thrombin activitable fibrinolysis inhibitor (TAFI) in Egyptian children with hemophilia A4
Clinical profile and outcome of children with anaplastic large cell lymphoma treated with short-course chemotherapy – ten years experience from a tertiary care center in a LMIC4
Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study4
How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist4
Methotrexate concentrations and associated variability factors in high dose therapy of children with acute lymphoblastic leukemia and non-Hodgkin lymphoma4
Advancing the Care of Pediatric Rare Solid Tumors: A virtual rare tumor board4
Late effects care for childhood brain Tumor Survivors: A Quality-Improvement Initiative4
Early Decline of Neuron-Specific Enolase during Neuroblastoma Chemotherapy is a Predictive Factor of Clinical Outcome4
The relationship between circulating tumor cells in peripheral blood and clinical characteristics of pediatric neuroblastoma and prognostic evaluation4
The clinicopathological profile and value of multidisciplinary management of pediatric brain tumors in a low-income setting4
Global caregiver concerns of SARS-CoV-2 vaccination in children with cancer: a cross-sectional mixed-methods study4
Co-transplantation of umbilical cord mesenchymal stem cells and peripheral blood stem cells in children and adolescents with refractory or relapsed severe aplastic anemia4
Impact of minimal residual disease on relapse in childhood acute lymphoblastic leukemia: Lessons learnt from a tertiary cancer center in India4
Changes in anthropometrical status and body composition in children with cancer during initial chemotherapy3
Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study3
Substrate oxidation during exercise in childhood acute lymphoblastic leukemia survivors3
Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) – a case series3
Haploidentical hematopoietic cell transplant for severe aplastic anemia in children with carbapenem-resistant enterocolitis3
Clinical characteristics and successful treatment outcomes of children and adolescents with Kaposi sarcoma in Southwestern Tanzania3
Impact of restrictive measures due to the Covid-19 pandemic on the incidence of immune thrombocytopenia in children: an Italian single center experience3
The Onset of Puberty Presents Unique Management Issues in Penile Chronic Graft-versus-Host Disease Requiring Circumcision in Male Pediatric Patients3
Diverse outcomes in extra-cranial rhabdoid tumors: A single institute experience3
Assessment of depression in children and adolescents with sickle cell anemia in a low-resource setting: a comparative study2
Sickle-Cell Disease and Stroke: Quality of Life of Patients in a Chronic Transfusion Regimen from the Caregivers’ Perspective2
Hospital acquired venous thromboembolism in children with sickle cell disease2
German physicians’ perceptions and views on complementary medicine in pediatric oncology: a qualitative study2
Safety and Tolerability of a 3-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients: Results of an Open-Label, Single-Arm Phase 4 Trial2
Levofloxacin prophylaxis in pediatric oncology and hematopoietic stem cell transplantation: a literature review2
Vitamin D deficiency in a pediatric population with sickle cell disease2
Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity2
Vincristine-induced neurotoxicity in pediatric patients with rhabdomyosarcoma: A retrospective analysis of clinical features and outcome2
Clonal hematopoiesis of indeterminate potential is rare in pediatric patients undergoing autologous stem cell transplantation2
Allogeneic hematopoietic stem cell transplantation in an adolescent with Prader-Willi syndrome – unique considerations2
Priapism from myeloid sarcoma of the sacral canal in a 6-year-old patient2
Hypothyroidism in children with Hb E/β-thalassemia compared between those who received regular transfusion and those who underwent hematopoietic stem cell transplantation2
Gonadal health in recipients of nonmyeloablative hematopoietic stem cell transplantation in children and adolescents with sickle cell disease2
Characterizing age-related differences in Hodgkin lymphoma in children, adolescents and young adults2
Thalassemia patients in transfussion dependent period and after hematopoietic stem cell transplantation: how are the psychiatric status and life quality of these patients?2
Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults wi2
The efficacy and safety of midazolam with fentanyl versus midazolam with ketamine for bedside invasive procedural sedation in pediatric oncology patients: A randomized, double-blinded, crossover trial2
Letter to editor regarding “Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument”2
Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience2
Pediatric AML: state of the Art and Future Directions2
Combined immunodeficiency with marginal zone lymphoma due to a novel homozygous mutation inIL-21Rgene and successful treatment with hematopoietic stem cell transplantation2
Treatment of Langerhans cell histiocytosis with subcutaneous cytarabine2
Temporal trends in pediatric cancer mortality: rare cancers lag behind more common cancers2
Hematopoietic Stem Cell Transplantation in Children with Sickle Cell Disease and Thalassemia Major: A National Database Study2
A case control analysis of pattern and risk factors for pulmonary dysfunction amongst childhood cancer survivors: a single centre study from a low-middle income setting2
The effects of NUDT15 and TPMT variants on mercaptopurine treatment in Vietnamese pediatric acute lymphoblastic leukemia patients2
Potential role of serum vitamin D as a risk factor in pediatric acute lymphoblastic leukemia2
Specific cytokine patterns in Epstein-Barr virusassociated hemophagocytic lymphohistiocytosis compared to Kawasaki disease in children2
Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome2
Psychosocial and mental profile of children with sickle cell disease and their caregivers2
Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of LEF12
Consensus survey on the management of children with chemotherapy-induced febrile neutropenia and at low risk of severe infection2
Evaluation of pharmacological efficacy and safety of hydroxyurea in sickle cell disease: Study of a pediatric cohort from Chhattisgarh, India2
Quantitative analysis of IKZF1 gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia: higher levels are associated with a poorer prognosis2
Development and field testing of a neuro psychomotor multidimensional grid for the assessment of children with cns tumor2
0.097495079040527